We are live on ! Find out more
AURA icon

Aura Biosciences
AURA

106 hedge funds and large institutions have $319M invested in Aura Biosciences in 2025 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 35 increasing their positions, 25 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

40% more repeat investments, than reductions

Existing positions increased: 35 | Existing positions reduced: 25

15% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 13

2% more funds holding

Funds holding: 104 → 106 (+2)

1% more capital invested

Capital invested by funds: $317M → $319M (+$2.33M)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

17.55% less ownership

Funds ownership: 100.69% → 83.14% (-18%)

Holders
106
Holders Change
+2
Holders Change %
+1.92%
% of All Funds
1.39%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
15
Increased
35
Reduced
25
Closed
13
Calls
$4K
Puts
–
Net Calls
+$4K
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$2.7M
2
Geode Capital Management
Geode Capital Management
Massachusetts
+$2.14M
3
BlackRock
BlackRock
New York
+$1.98M
4
LCS
Levin Capital Strategies
New York
+$861K
5
Walleye Capital
Walleye Capital
New York
+$440K

Top Sellers

Rank Fund Capital Flow
1
SB
Samsara BioCapital
California
-$2.71M
2
Franklin Resources
Franklin Resources
California
-$928K
3
Wellington Management Group
Wellington Management Group
Massachusetts
-$407K
4
HF
HRT Financial
New York
-$353K
5
RCM
Regency Capital Management
Hawaii
-$348K
Name Holding Trade Value Shares
Change 		Change in
Stake
Morgan Stanley
26
Morgan Stanley
New York
$1.1M +$185K +28,217 +19%
PCM
27
Permanent Capital Management
Illinois
$913K +$966K +147,769 New
PIM
28
Platinum Investment Management
Australia
$837K – – –
Charles Schwab
29
Charles Schwab
California
$834K +$100K +15,297 +13%
Wellington Management Group
30
Wellington Management Group
Massachusetts
$787K -$407K -62,173 -33%
Ameriprise
31
Ameriprise
Minnesota
$746K +$237K +36,182 +43%
Renaissance Technologies
32
Renaissance Technologies
New York
$603K -$222K -33,940 -26%
Bank of New York Mellon
33
Bank of New York Mellon
New York
$592K +$16.1K +2,455 +3%
RCAP
34
Resolute Capital Asset Partners
Colorado
$562K – – –
N
35
Nuveen
North Carolina
$447K – – –
RhumbLine Advisers
36
RhumbLine Advisers
Massachusetts
$427K +$23.7K +3,630 +6%
TD Asset Management
37
TD Asset Management
Ontario, Canada
$427K – – –
Walleye Capital
38
Walleye Capital
New York
$416K +$440K +67,296 New
Barclays
39
Barclays
United Kingdom
$401K -$23.7K -3,619 -5%
TGAM
40
TBH Global Asset Management
Tennessee
$373K – – –
Manulife (Manufacturers Life Insurance)
41
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$369K -$5.97K -913 -2%
SPS
42
Susquehanna Portfolio Strategies
Pennsylvania
$351K – – –
PCM
43
Prelude Capital Management
New York
$309K +$327K +50,000 New
Deutsche Bank
44
Deutsche Bank
Germany
$281K +$297K +45,455 New
QCM
45
Quantinno Capital Management
New York
$276K +$149K +22,769 +104%
ECM
46
ExodusPoint Capital Management
New York
$268K -$844 -129 -0.3%
Royal Bank of Canada
47
Royal Bank of Canada
Ontario, Canada
$263K +$25.5K +3,903 +10%
AllianceBernstein
48
AllianceBernstein
Tennessee
$257K – – –
American Century Companies
49
American Century Companies
Missouri
$239K -$54.6K -8,356 -18%
Bank of America
50
Bank of America
North Carolina
$224K +$69K +10,550 +41%
1
2
3 4 5

AURA Hedge Fund Activity: Q3 2025 in Review

106 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q3 2025, worth a combined $319M — up 0.73% from $317M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new AURA positions and 13 closed out — a net gain of 2 holders — while 35 added to existing stakes and 25 trimmed.

The largest buyer was Vanguard Group, adding an estimated $2.7M. The largest seller was Samsara BioCapital, cutting an estimated $2.71M.

  • 106 institutional investors held Aura Biosciences (AURA) as of Q3 2025, up from 104 in Q2 2025.
  • Funds reported $319M of Aura Biosciences stock for Q3 2025, up 0.73% quarter-over-quarter.
  • 15 funds opened new Aura Biosciences positions in Q3 2025 and 13 closed out, a net change of +2 holders.
  • The largest Aura Biosciences buyer in Q3 2025 was Vanguard Group, an estimated $2.7M added.
  • The largest Aura Biosciences seller in Q3 2025 was Samsara BioCapital, an estimated $2.71M sold.

Based on aggregated 13F filings for Q3 2025.